211 related articles for article (PubMed ID: 11102751)
1. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.
Ye S
Matrix Biol; 2000 Dec; 19(7):623-9. PubMed ID: 11102751
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage.
Zhang B; Dhillon S; Geary I; Howell WM; Iannotti F; Day IN; Ye S
Stroke; 2001 Sep; 32(9):2198-202. PubMed ID: 11546917
[TBL] [Abstract][Full Text] [Related]
3. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function.
Joos L; He JQ; Shepherdson MB; Connett JE; Anthonisen NR; Paré PD; Sandford AJ
Hum Mol Genet; 2002 Mar; 11(5):569-76. PubMed ID: 11875051
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.
Lamblin N; Bauters C; Hermant X; Lablanche JM; Helbecque N; Amouyel P
J Am Coll Cardiol; 2002 Jul; 40(1):43-8. PubMed ID: 12103254
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis.
Wu XY; Chen MB; Wang LQ; Xu Y; Tan Y; Shen WX
Breast Cancer Res Treat; 2011 Nov; 130(1):357-8. PubMed ID: 21671019
[No Abstract] [Full Text] [Related]
7. Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm.
Kazi M; Zhu C; Roy J; Paulsson-Berne G; Hamsten A; Swedenborg J; Hedin U; Eriksson P
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1341-6. PubMed ID: 15845912
[TBL] [Abstract][Full Text] [Related]
8. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.
Jormsjö S; Ye S; Moritz J; Walter DH; Dimmeler S; Zeiher AM; Henney A; Hamsten A; Eriksson P
Circ Res; 2000 May; 86(9):998-1003. PubMed ID: 10807873
[TBL] [Abstract][Full Text] [Related]
9. Histone Methylation and STAT-3 Differentially Regulate Interleukin-6-Induced Matrix Metalloproteinase Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts.
Araki Y; Tsuzuki Wada T; Aizaki Y; Sato K; Yokota K; Fujimoto K; Kim YT; Oda H; Kurokawa R; Mimura T
Arthritis Rheumatol; 2016 May; 68(5):1111-23. PubMed ID: 26713842
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
12. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions.
Roach HI; Yamada N; Cheung KS; Tilley S; Clarke NM; Oreffo RO; Kokubun S; Bronner F
Arthritis Rheum; 2005 Oct; 52(10):3110-24. PubMed ID: 16200590
[TBL] [Abstract][Full Text] [Related]
13. Analysis of two polymorphisms in the promoter region of matrix metalloproteinase 1 and 3 genes in women with endometriosis.
Ferrari MM; Biondi ML; Rossi G; Grijuela B; Gaita S; Perugino G; Viganò P
Acta Obstet Gynecol Scand; 2006; 85(2):212-7. PubMed ID: 16532917
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.
Salmela MT; MacDonald TT; Black D; Irvine B; Zhuma T; Saarialho-Kere U; Pender SL
Gut; 2002 Oct; 51(4):540-7. PubMed ID: 12235077
[TBL] [Abstract][Full Text] [Related]
15. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
[TBL] [Abstract][Full Text] [Related]
16. Lack of an association between matrix metalloproteinase polymorphisms and coronary heart disease in a Han Chinese population.
Wang CM; Ye HD; Li YR; Hong QX; Tang LL; Zhou AN; Xu MQ; Duan SW
Genet Mol Res; 2015 Oct; 14(4):12254-61. PubMed ID: 26505374
[TBL] [Abstract][Full Text] [Related]
17. Regulation of matrix metalloproteinase gene expression.
Yan C; Boyd DD
J Cell Physiol; 2007 Apr; 211(1):19-26. PubMed ID: 17167774
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.
Galboiz Y; Shapiro S; Lahat N; Rawashdeh H; Miller A
Ann Neurol; 2001 Oct; 50(4):443-51. PubMed ID: 11601495
[TBL] [Abstract][Full Text] [Related]
20. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
